1. Home
  2.  » 
  3. Behind The "News"
  4.  » 
  5. Current Affairs
  6.  » Trans children who took puberty-blocking drugs had mental health issues, UK study found

Introduction – Sept 25, 2023

The journalist who wrote this report seems oblivious to the REAL QUESTION here. So too is the study commissioned to look into the matter.

It should be obvious:

Were these kid’s mental health issues caused by the puberty blocking drugs? Or were their mental health problems the ACTUAL CAUSE OF THEIR GENDER IDENTIFICATION ISSUES in the first place?

According to Fox News the subjects of the study were deemed ‘”psychologically stable,” but all of them had been classified as having gender dysphoria’. As if ‘gender dysphoria’ war a normal part of growing up.

It’s not but is seems that Fox News and the study commissioned to look into the matter would have us believe that it was. Ed.

Melissa Rudy – Fox News Sept 23, 2023

Taking puberty-blocking drugs has been shown to cause mental health issues in trans children, according to a recent analysis from the University of Essex.

In re-examining the results of a previous study, the U.K. researchers determined that one-third of the youth with gender dysphoria (GD) experienced a decline in mental health after taking triptorelin.

Sold under the brand name Trelstar, triptorelin is a gonadotropin-releasing hormone (GnRH) agonist that reduces the amount of certain hormones in the body.

The original study, which came from NHS’s Gender Identity Development Service (GIDS) at Tavistock and University College London Hospitals (UCLH) in 2021, analyzed 44 children between the ages of 12 and 15 who took puberty-blocking drugs.

The children were all deemed “psychologically stable,” but all of them had been classified as having gender dysphoria, with a “high likelihood of extreme psychological distress with ongoing pubertal development,” the study authors wrote in the journal entry discussing the findings.

At the time, the researchers determined that the drugs had no impact on the kids’ mental health over a 36-month follow-up period.

The new analysis of the study, however, determined that 34% of the trans youth experienced a decline in mental health while taking puberty blockers.

At the same time, 37% reported no change in mental health and 29% noticed an improvement.

To determine the extent of mental health changes, the researchers looked at emotional factors (anxiety, depression, social withdrawals and somatic complaints) as well as behavioral signals, such as attention problems and aggressive behaviors, according to the researchers. They also analyzed sleep difficulties.

While the original study combined the overall average of all kids’ mental well-being, the new analysis looked at each child’s individual psychological health, which revealed more variation among them.

“This is the first analysis of U.K. data on children aged 12 to 15 with GD taking puberty blockers demonstrating individual level change as opposed to testing differences between group averages,” the study authors wrote in a journal entry describing the findings. “As such, this analysis gives a fuller picture of the benefits and risks of treatment.”

The new analysis determined that 34% of the trans youth experienced a decline in mental health while taking puberty blockers.

“We recommend that these approaches be incorporated into new gender dysphoria services being established in the U.K., as well as new research studies being designed,” they added.

The new analysis was posted to medRxiv, a preprint service for health studies, but has not yet been peer-reviewed.

The study did have some limitations. It included a small sample size of youth and there was no control group. There was also a limited dataset available for the children who were studied.

Also, the results show association but not necessarily causation, as there may have been other factors that could have affected the children’s mental health.

A spokesperson from Tavistock and Portman Trust, which conducted the original study, provided the following statement to the Daily Mail:

“We are grateful to all of the clinicians and academics who have contributed to this study over the years, and we welcome new peer-reviewed analyses of the evidence around how to support these young people.”

“The analysis plan for the original study was independently produced by experts in medical statistics, and the underlying data was published so that other researchers might conduct further analyses.”

Fox News Digital has reached out to Tavistock and Portman Trust for further comment.

Continues …